Evolving the treatment paradigm in cold agglutinin disease (CAD): Challenges and opportunities for optimal management - European Medical Journal

Evolving the treatment paradigm in cold agglutinin disease (CAD): Challenges and opportunities for optimal management

Hematology
Date: Thursday, 8 June 2023 | 14:45–16:15 CET
Location: Illusion Room, Messe Frankfurt in Frankfurt, Germany
Prof. Alexander Röth (Chair), Prof. Wilma Barcellini, Prof. Josephine Vos and Prof. Bernd Jilma, will discuss about the evolving treatment paradigm in cold agglutinin disease (CAD): challenges and opportunities for optimal management.

Agenda:

  • Introduction: 0:00 – 5:15
    Alexander Röth, MD, Germany (Chair)
  • Recognising CAD as a chronic disease: 5:15 – 19:38
    Wilma Barcellini, MD, Italy
  • Understanding the overall impact of CAD on patients’ lives: 19:38 – 36:52
    Josephine Vos, MD, The Netherlands
  • A closer look at real-world experiences of CAD in the clinic: Challenges and opportunities: 36:52 – 50:40
    Bernd Jilma, MD, Austria
  • Optimising treatment pathways in CAD: 50:40 – 1:13:00
    Alexander Röth, MD, Germany
  • Q&A: 1:13:00 – 1:33:03
    Moderated by Chair

This content is supported by Sanofi

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>